Rufo J, Zhang P, Wang Z, Gu Y, Yang K, Rich J
Microsyst Nanoeng. 2024; 10:23.
PMID: 38317693
PMC: 10838941.
DOI: 10.1038/s41378-023-00648-3.
Yin Z, Xiao S, Tian X, Yuan Z, Zhou L
Saudi J Gastroenterol. 2022; 28(5):385-392.
PMID: 35259858
PMC: 9752539.
DOI: 10.4103/sjg.sjg_638_21.
Miyoshi J, Zhu Z, Luo A, Toden S, Zhou X, Izumi D
Mol Cancer. 2022; 21(1):44.
PMID: 35148754
PMC: 8832722.
DOI: 10.1186/s12943-022-01507-x.
Rocafort M, Henares D, Brotons P, Barrabeig I, Launes C, Merdrignac L
PLoS One. 2021; 16(10):e0259318.
PMID: 34714887
PMC: 8555781.
DOI: 10.1371/journal.pone.0259318.
Li Z, Lv M, Peng D, Xiao X, Fang Z, Wang Q
Int J Legal Med. 2021; 135(6):2247-2261.
PMID: 34477924
DOI: 10.1007/s00414-021-02678-w.
Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases.
Ding H, Wang Y, Hu L, Xue S, Wang Y, Zhang L
Biosci Rep. 2020; 40(3).
PMID: 32124924
PMC: 7080642.
DOI: 10.1042/BSR20191653.
Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR.
Ding Y, Wang Q, Li D, Yao K, Wang T
Eur J Clin Microbiol Infect Dis. 2019; 39(3):501-507.
PMID: 31797154
DOI: 10.1007/s10096-019-03750-5.
Should equivocal PCR results in children be reported to public health?.
Desjardins M, Mousseau S, Doyon-Plourde P, Brousseau N, Iachimov D, Rallu F
Can Commun Dis Rep. 2019; 44(9):196-200.
PMID: 31015809
PMC: 6449112.
DOI: 10.14745/ccdr.v44i09a02.
A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer.
Lin Y, Leng Q, Zhan M, Jiang F
Transl Oncol. 2018; 11(5):1225-1231.
PMID: 30098474
PMC: 6089091.
DOI: 10.1016/j.tranon.2018.07.016.
A Direct Plasma miRNA Assay for Early Detection and Histological Classification of Lung Cancer.
Leng Q, Wang Y, Jiang F
Transl Oncol. 2018; 11(4):883-889.
PMID: 29783093
PMC: 6041566.
DOI: 10.1016/j.tranon.2018.05.001.
GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions.
Bustos V, Nolan A, Nijhuis A, Harvey H, Parker A, Poulsom R
Oncotarget. 2017; 8(48):84258-84275.
PMID: 29137421
PMC: 5663593.
DOI: 10.18632/oncotarget.20653.
Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma.
Weber D, Gawrych K, Casjens S, Brik A, Lehnert M, Taeger D
Dis Markers. 2017; 2017:9280170.
PMID: 28321148
PMC: 5339541.
DOI: 10.1155/2017/9280170.
Effectiveness of pertussis vaccination and duration of immunity.
Schwartz K, Kwong J, Deeks S, Campitelli M, Jamieson F, Marchand-Austin A
CMAJ. 2016; 188(16):E399-E406.
PMID: 27672225
PMC: 5088088.
DOI: 10.1503/cmaj.160193.
Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung.
Demes M, Aszyk C, Bartsch H, Schirren J, Fisseler-Eckhoff A
Cancers (Basel). 2016; 8(4).
PMID: 27023611
PMC: 4846847.
DOI: 10.3390/cancers8040038.
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.
OBrien K, Lowry M, Corcoran C, Martinez V, Daly M, Rani S
Oncotarget. 2015; 6(32):32774-89.
PMID: 26416415
PMC: 4741729.
DOI: 10.18632/oncotarget.5192.
Laboratory Diagnosis of Pertussis.
van der Zee A, Schellekens J, Mooi F
Clin Microbiol Rev. 2015; 28(4):1005-26.
PMID: 26354823
PMC: 4575397.
DOI: 10.1128/CMR.00031-15.
Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity.
Bolotin S, Deeks S, Marchand-Austin A, Rilkoff H, Dang V, Walton R
PLoS One. 2015; 10(7):e0133209.
PMID: 26186564
PMC: 4505870.
DOI: 10.1371/journal.pone.0133209.
Emerging technologies for the clinical microbiology laboratory.
Buchan B, Ledeboer N
Clin Microbiol Rev. 2014; 27(4):783-822.
PMID: 25278575
PMC: 4187641.
DOI: 10.1128/CMR.00003-14.
Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran.
Nikbin V, Shahcheraghi F, Nakhost Lotfi M, Zahraei S, Parzadeh M
Iran J Microbiol. 2014; 5(3):209-14.
PMID: 24475325
PMC: 3895556.
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer.
Weber D, Johnen G, Casjens S, Bryk O, Pesch B, Jockel K
BMC Res Notes. 2013; 6:518.
PMID: 24313945
PMC: 4029199.
DOI: 10.1186/1756-0500-6-518.